ETR:SRT - Sartorius Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
€144.50 +7.00 (+5.09 %)
(As of 04/23/2019 12:05 PM ET)
Previous Close€137.50
Today's Range€139.00 - €145.00
52-Week Range€90.40 - €150.00
Volume2,237 shs
Average VolumeN/A
Market Capitalization$9.88 billion
P/E Ratio69.91
Dividend Yield0.43%
BetaN/A
Sartorius Aktiengesellschaft supplies pharmaceutical and laboratory equipment worldwide. It operates in two divisions, Bioprocess Solutions, and Lab Products & Services. The company offers products for suspension cell analysis and live-cell analysis inside incubator for oncology, immuno-oncology, antibody discovery, neuroscience, and stem cell research; cell culture media, including antibody and recombinant protein, viral vaccines, and regenerative medicine media, as well as general media and downstream buffers; and multi-parallel, single-use, benchtop, stainless steel, microbial, and cell culture bioreactors, as well as cell culture expansion systems and software applications for bioreactors. It also provides lab filtration and purification devices; sterile and virus filtration, crossflow filtration, harvesting, prefiltration, membrane chromatography, air/gas filtration, and integrity testing devices; and liquid storage and shipping, freeze and thaw, mixing, proven integrity, transferring and sampling, connecting and disconnecting, and final filling management products. In addition, the company offers process control and data analytics products, such as process analyzers, automation modules, and data analytics and chemometrics; and microbiology products, and lab water purification systems. Further, it provides lab balances, mass comparators and metrology, moisture analyzers, specialty weighing solutions, weighing accessories, weights/weight sets, paint mixing solutions, and OEM weigh cells; and OEM membrane and device, pipetting and dispensing, and connectivity solutions. Additionally, the company offers bioprocess development engineering, protein expression system, media and process, testing, instrument, and validation services. It serves the life science research, biopharmaceutical manufacturing, quality control and testing, food and beverage, environmental, and paint mixing industries. The company was founded in 1870 and is headquartered in Göttingen, Germany.

Receive SRT News and Ratings via Email

Sign-up to receive the latest news and ratings for SRT and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Diagnostics & Research
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone49 551 308 0

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$1.57 billion
Cash Flow€0.99 per share
Book Value€10.83 per share

Profitability

Miscellaneous

Employees8,125
Market Cap$9.88 billion
Next Earnings DateN/A
OptionableOptionable

Sartorius (ETR:SRT) Frequently Asked Questions

What is Sartorius' stock symbol?

Sartorius trades on the ETR under the ticker symbol "SRT."

What price target have analysts set for SRT?

8 brokerages have issued 12 month target prices for Sartorius' shares. Their predictions range from €93.00 to €142.00. On average, they expect Sartorius' share price to reach €114.88 in the next year. This suggests that the stock has a possible downside of 20.5%. View Analyst Price Targets for Sartorius.

What is the consensus analysts' recommendation for Sartorius?

8 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Sartorius in the last year. There are currently 4 sell ratings and 4 hold ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Sartorius.

Has Sartorius been receiving favorable news coverage?

News coverage about SRT stock has been trending positive this week, InfoTrie Sentiment Analysis reports. InfoTrie identifies positive and negative media coverage by reviewing more than six thousand blog and news sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores closest to five being the most favorable. Sartorius earned a media sentiment score of 2.7 on InfoTrie's scale. They also assigned press coverage about the company a news buzz of 1.0 out of 10, indicating that recent media coverage is extremely unlikely to have an effect on the stock's share price in the near future.

Who are some of Sartorius' key competitors?

What other stocks do shareholders of Sartorius own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Sartorius investors own include Micron Technology (MU), Lendlease Group (LLC), Velocity Data (VCT), Align Technology (ALGN), Ctrip.Com International (CTRP), Cytokinetics (CYTK), Endologix (ELGX), Gulfport Energy (GPOR), American Eagle Outfitters (AEO) and AAR (AIR).

Who are Sartorius' key executives?

Sartorius' management team includes the folowing people:
  • Dr. Joachim Kreuzburg, Chairman of Exec. Board & CEO (Age 54)
  • Mr. Rainer Lehmann, CFO & Member of Exec. Board and Head of Fin., Information Technology & Bus. Process (Age 43)
  • Ms. Petra Kirchhoff, Head of Corp. Communications & Investor Relations and Member of Supervisory Board (Age 50)
  • Mr. Gerry Mackay, Head of Lab Products & Services Division & Member of Exec. Board (Age 56)
  • Dr. René Fáber, Head of Bioprocess Solutions Division & Member of Exec. Board (Age 43)

What is Sartorius' stock price today?

One share of SRT stock can currently be purchased for approximately €144.50.

How big of a company is Sartorius?

Sartorius has a market capitalization of $9.88 billion and generates $1.57 billion in revenue each year. Sartorius employs 8,125 workers across the globe.

What is Sartorius' official website?

The official website for Sartorius is http://www.sartorius.com.

How can I contact Sartorius?

The company can be reached via phone at 49 551 308 0.


MarketBeat Community Rating for Sartorius (ETR SRT)

Community Ranking:  1.9 out of 5 (star)
Outperform Votes:  25 (Vote Outperform)
Underperform Votes:  41 (Vote Underperform)
Total Votes:  66
MarketBeat's community ratings are surveys of what our community members think about Sartorius and other stocks. Vote "Outperform" if you believe SRT will outperform the S&P 500 over the long term. Vote "Underperform" if you believe SRT will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 4/23/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel